TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 0.900nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 3.80nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 4.40nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 4.60nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 5nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 5.40nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 9.90nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 23nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 54nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 69nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 82nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 82nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 86nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 93nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 150nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 170nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 170nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 190nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 220nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 250nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 300nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 450nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 540nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: >540nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 540nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 540nMAssay Description:Inhibitory activity against HIV-1 ProteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 710nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Group Research
Glaxo Group Research
Affinity DataIC50: 1.90E+3nMpH: 6.0 T: 2°CAssay Description:IC50 values were obtained by assaying the enzyme against the synthetic substrate peptide KQGTVSFNFPQIT, which was tritiated at the proline residue, a...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Glaxo Research And Development
Curated by ChEMBL
Glaxo Research And Development
Curated by ChEMBL
Affinity DataIC50: >2.20E+3nMAssay Description:In vitro inhibitory activity against HIV proteinaseMore data for this Ligand-Target Pair